查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2026706

全球周邊血管支架市場：規模、佔有率和趨勢分析（2024-2030 年）

Peripheral Vascular Stent Market Size, Share, and Trends Analysis | Global | 2024-2030 | Includes: Arterial, Bare-Metal, Covered, Drug-Eluting, Venous Stent Markets
出版日期: | 出版商: iData Research Inc. | 英文 158 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球周邊血管支架市場報告

2025年全球周邊血管支架市場規模為29億美元。在預測期內，該市場預計將以2.8%的複合年成長率成長，到2032年將達到35億美元。

  • 這份關於全球周邊血管支架市場的綜合報告涵蓋七個區域：北美、拉丁美洲、西歐、中東歐、中東、亞太地區和非洲。報告針對每個區域，提供詳細的市場規模、銷售量分析、平均售價數據、至2032年的預測以及截至2022年的歷史數據。報告結構參照附件中的範例文檔，遵循清晰的流程，從執行摘要到市場動態、市場區隔、競爭分析和最終成果，一目了然。

本報告聚焦於全球周邊血管支架市場，並將其細分為動脈支架和靜脈支架。除市場規模和預測外，分析內容還包括銷售量、手術量、市場佔有率、平均售價、成長趨勢、市場促進因素和限制因素、近期併購、公司概況、產品系列以及主要企業。最終呈現的是對周邊血管介入領域這一成熟且不斷發展的細分市場的深入分析。

塑造這一市場的關鍵趨勢之一是藥物釋放型支架在周邊動脈疾病治療中的持續應用。這些裝置旨在將藥物直接輸送到治療部位，從而降低血管再阻塞並改善長期血管通暢性。隨著臨床證據不斷積累，支持其在特定周邊血管疾病治療中的有效性，藥物釋放型支架有望在全球治療模式中發揮更大的作用。同時，覆膜支架和低剖面支架的出現正在擴大支架治療的適用範圍。

市場概覽

全球周邊血管支架市場包括用於維持周邊動脈和靜脈血管通暢性的植入式裝置。這些支架廣泛應用於各種臨床疾病，包括髂動脈疾病、股膕動脈疾病、膝下介入治療、靜脈阻塞以及其他周邊血管疾病，在這些疾病中，維持血管通暢性對於長期治療的成功至關重要。

周邊血管支架仍是血管內治療的核心，因為它們能提供持久的支撐結構，並能解決血管成形術後的回縮、撕裂和血管塌陷等問題。然而，如今的市場比以往任何時候都更加複雜。醫生不再將支架作為所有病變類型的首選治療方案。相反，支架的選擇越來越受到病變複雜程度、解剖位置、預期長期療效以及是否需要確保未來再次治療方案等因素的影響。

周邊血管支架市場的另一個特徵是成熟與創新之間的平衡。一些主要的支架適應症，例如股膕動脈和髂動脈的應用，已經成熟並進入了較成熟的成長階段。同時，產品研發也不斷提升效能，這主要得益於持續的研究，尤其是在覆膜設計、低輪廓輸送系統和藥物釋放型技術方面。因此，儘管市場仍然保持成長，但新的價值創造往往並非僅依靠手術數量的顯著增加，而是源自於產品成分和技術的升級。

市場促進因素

覆膜支架的廣泛應用

全球周邊血管支架市場最重要的促進因素之一是覆膜支架的日益普及。隨著髂動脈、腎動脈、表動脈和動靜脈通路手術中覆膜支架的核准不斷擴大，醫師在治療複雜疾病方面擁有了更靈活的選擇。覆膜支架之所以越來越受歡迎，是因為它們可以降低支架內血管再阻塞的發生率，即使發生再血管再阻塞，也能更容易處理。在許多動脈植入病例中，狹窄通常僅限於近端，這簡化了再次治療。

藥物釋放型支架

藥物釋放型支架也是主要的成長要素，儘管該領域過去曾經歷過動盪。雖然市場在2019年遭受了負面衝擊，但從長遠來看，藥物釋放型支架有望成為整個周邊血管支架市場中成長最快的細分市場。臨床需求依然強勁，尤其是在那些降低血管再阻塞至關重要且長期通暢性足以抵消較高器械成本的病變部位。

隨著更多臨床研究的發表以及製造商在該領域不斷創新，藥物釋放型支架預計仍將是關鍵的研發領域。每種器械相對較高的價格也意味著其普及應用可能會對市場價值產生顯著影響。此外，膝下病變治療的不斷拓展也凸顯了高性能支架技術在更具挑戰性的解剖結構中日益重要的角色。

小直徑、低輪廓支架

低輪廓支架的出現推動了市場發展，使得以往使用較大尺寸器械無法或難以實施的手術得以實現。較小直徑的支架系統能夠進入更狹窄、更難進入的血管，為醫生治療遠端疾病和更複雜的解剖結構提供了更大的靈活性。這在下肢疾病中尤其重要，因為下肢疾病的治療難度較大，病變長度、血管大小等因素都會增加治療難度。

隨著支架體積不斷縮小，更多患有嚴重下肢缺血或其他晚期周邊血管疾病的患者將能夠接受支架治療。這將擴大符合治療條件的患者群體，並提高支架在更廣泛適應症中的效用。這些設計改進也是治療手段更精準、創傷更小這一大趨勢的一部分。

市場限制

紫杉醇類藥物退出市場的趨勢

周邊血管支架市場的主要阻礙因素之一是，在FDA對紫杉醇在周邊血管中的應用展開調查後，紫杉醇製劑的使用逐漸減少。自2019年以來，醫生們的擔憂對該領域產生了顯著的負面影響，尤其是依賴紫杉醇的藥物釋放型技術。儘管市場預計會隨著時間的推移而復甦，但復甦的速度將取決於能否重獲醫生的信心、持續的臨床研究以及持續的創新。

從長遠來看，末梢用藥物釋放型支架所使用的藥物平台有望持續發展。這項轉變需要進一步的研究、臨床試驗和投資。在新的方法得到充分檢驗並被醫生廣泛接受之前，這種不確定性將繼續限制藥物洗脫支架的成長速度，使其低於先前的預期。

市場成熟度

另一個主要的阻礙因素是市場成熟度，尤其是在股膕動脈和髂動脈支架植入術領域。雖然這兩個領域是周邊動脈支架植入術中最大的細分市場，但它們已不再處於早期成長階段。在許多國家，這些適應症已經相當成熟，預計手術數量的成長將與人口老化相一致，而不是與快速擴張相一致。

這種成熟度限制了該品類的整體成長潛力，因為新產品進入市場通常是對現有技術的替代或升級，而不是創造全新的需求。因此，成長往往更依賴產品組合、價格差異和交易量的逐步提升，而不是需求的劇烈變化。

支架置入術後併發症

支架植入術後併發症也會影響市場成長。支架內狹窄仍然是多種類型支架植入術後的常見問題，通常需要持續管理，包括血栓切除術以確認血管通暢性和支架位置，以及定期進行診斷追蹤。由於永久植入的裝置可能會使未來的治療選擇複雜化，許多醫生在選擇支架植入時機時變得越來越謹慎。

這一趨勢是避免在某些情況下植入永久性植入的更廣泛趨勢的一部分。藥物釋放型球囊和聯合治療提供了無需在體內留下永久性支架的治療途徑，同時為未來留下了更多選擇。隨著這些替代療法的普及，將支架植入作為首選治療方案的病例數量可能會減少。

市場覆蓋範圍和數據範圍

定量研究範圍

市場規模、市佔率、市場預測、市場成長率、銷售量、平均售價。

定性研究範圍

市場促進因素和限制因素、成長趨勢、競爭分析、近期併購、公司簡介、產品系列和主要競爭對手。

目標期

基準年：2025 年，歷史資料截至 2022 年，預測至 2032 年。

區域分析

北美洲、拉丁美洲、西歐、中歐和東歐、中東、亞太地區、非洲。

包含的資料類型

銷售量、平均售價、治療次數、市場規模和成長趨勢。

本報告旨在提供全球周邊血管支架市場的策略和營運可視性，包含足夠的詳細資訊以幫助進行預測、競爭基準分析和產業計畫。

目標市場及區隔

  • 本報告涵蓋全球周邊血管支架市場，並將其進一步細分為以下幾個部分：

動脈支架市場

此部分包括用於動脈適應症的周邊血管支架，例如髂動脈、股膕動脈、膝下動脈和其他周邊動脈的治療。

靜脈支架市場

此部分內容包括用於治療靜脈阻塞及相關靜脈疾病的支架。隨著靜脈介入治療技術的日益專業化，人們對這一領域的關注度也越來越高。

每個細分市場都採用市場規模、銷售量、治療數據和平均售價進行分析，並展示了到 2032 年的歷史趨勢和預測。

競爭分析

戈爾公司是全球周邊血管支架市場的領導者之一，尤其在塗層支架領域實力雄厚。其VIABAHN塗層支架平台的成功研發和商業化鞏固了公司的市場地位。諸如肝素塗層和低輪廓設計等持續改進進一步提升了其在該領域的競爭力。此外，用於表動脈和近端膕動脈的GORE TIGRIS自膨式血管支架獲得FDA核准，也為公司注入了強勁動力，進一步鞏固了其在周邊動脈治療領域的地位。

波士頓科學公司在多個關鍵周邊支架領域已確立了強大的市場地位。憑藉其Express LD和Express SD支架，該公司在髂動脈和腎動脈支架市場佔據了顯著佔有率。在靜脈支架領域，波士頓科學公司是領先的競爭者之一，憑藉Wallstent支架的現有市場佔有率，該公司推出了VICI支架。 VICI支架於2019年獲得美國核准，使該公司在國內外市場均保持了強勁的市場佔有率。

雅培在2025年排名第三。該公司研發的Xience Prime BTK支架於2011年獲得CE核准，在膝下（BTK）血管支架領域佔據了顯著的市場佔有率。雅培血管也提供球囊擴張型和自動擴張型支架，適用於多種周邊血管疾病。豐富的產品組合使公司能夠在成熟市場和更專業的領域中保持活躍的地位。

總體而言，全球周邊血管支架市場的競爭格局取決於產品廣度、特定病變類別的性能，以及在一個成熟但仍然重要的市場中，透過差異化技術為醫生提供支援的能力。

科技和醫療治療的發展趨勢

周邊血管支架市場最重要的技術趨勢之一是藥物釋放型支架在治療周邊動脈疾病的應用日益廣泛。這些裝置旨在將藥物直接釋放到植入部位，在某些情況下，與傳統的裸金屬支架相比，可以減少血管再阻塞並改善長期治療效果。

此外，越來越多的醫生在髂動脈、腎動脈、股淺動脈（SFA）和血管通路手術中使用覆膜支架，這正在擴大其市場佔有率。覆膜支架在某些複雜病灶中改善治療效果的能力，並持續推動其應用。

低輪廓支架也是主要趨勢。較小的支架可以治療較狹窄、更難觸及的血管，從而擴大了支架治療適用的周邊病變範圍。

同時，醫生們在治療方案的選擇上也變得更加謹慎。他們不再對所有類型的病灶都使用支架，而是越來越注重平衡支架置入術與球囊擴張術或聯合治療。這意味著，未來的市場成功不僅取決於擁有完整的支架產品線，還取決於支架技術是否適用於特定的臨床場景。

地區

本報告提供了涵蓋北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的全球研究成果。

這份文件包含詳細的市場分析、資料表和預測，共 174 頁。

調查方法附錄和簡稱詞彙表。

這份報告的意義

全球周邊血管支架市場中，最大、最穩定的商機在哪裡？

覆膜支架和藥物釋放型支架在動脈和靜脈應用中改變產品組合的速度有多快？

醫生對紫杉醇或支架植入後併發症的擔憂將如何影響未來器械的需求？

主要支架的適應症在多大程度上已經成熟？到 2032 年，哪些領域預計仍將有顯著成長？

在覆膜支架、靜脈支架和其他高價值類別中，哪些競爭對手已佔據最強的市場佔有率？

平均售價、銷售量和治療趨勢如何隨時間影響市場規模？

iData Research 的《全球周邊血管支架市場報告》透過詳細的市場規模、市場細分、競爭分析和預測模型解答了這些問題。您可以利用該報告與競爭對手進行比較，評估區域機遇，並在成熟但臨床意義重大的血管器械市場中製定成長計畫。

目錄

圖表清單

調查方法

  • 第一步：計劃啟動與團隊組建
  • 步驟 2：準備資料系統並進行二次調查。
  • 步驟三：訪談準備與調查問卷設計
  • 第四步：進行初步調查
  • 第五步：調查與分析：建立基準估計值
  • 第六步：市場預測與分析
  • 步驟 7：辨識策略機遇
  • 步驟 8：最終審核和市場推廣
  • 步驟九：客戶回饋與市場監測

全球關稅的影響

周邊血管支架市場

  • 執行摘要
    • 全球周邊血管支架市場概覽
    • 競爭分析
    • 目標程式
    • 目標市場
    • 目標區域
  • 介紹
    • 周邊動脈支架
    • 靜脈支架
  • 手術次數
    • 周邊血管支架置入術整體
    • 動脈支架置入術
    • 靜脈支架置入術
  • 市場概覽
    • 按細分市場
    • 按地區
  • 市場分析與預測
    • 動脈支架市場
    • 靜脈支架市場
  • 促進因素和抑制因素
  • 競爭性市佔率分析

簡稱

Product Code: iDATA_GLCPV26_PVS_MC

Global Peripheral Vascular Stent Market Report

The global peripheral vascular stent market was valued at $2.9 billion in 2025. Over the forecast period, the market is expected to grow at a CAGR of 2.8% to reach $3.5 billion by 2032.

  • The full report suite on the global peripheral vascular stent market covers seven geographical regions: North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia-Pacific and Africa. For each region, the report provides detailed market valuation, unit analysis and average selling price data, along with forecasts through 2032 and historical data to 2022. The report is structured in line with the attached example document and follows the same clear progression from executive summary through market dynamics, segmentation, competitive analysis and deliverables .

This report focuses on the global market for peripheral vascular stents and further segments the market into arterial stents and venous stents. In addition to market size and forecasts, the analysis includes unit sales, procedure numbers, market shares, average selling prices, growth trends, market drivers and limiters, recent mergers and acquisitions, company profiles, product portfolios and leading competitors. The result is a focused view of one of the most established yet still evolving categories in peripheral vascular intervention.

An important trend shaping this market is the continued adoption of drug-eluting stents for the treatment of peripheral arterial disease. These devices are designed to deliver medication directly at the treatment site, helping reduce restenosis and improving long-term vessel patency. As clinical evidence continues to support their effectiveness in selected peripheral applications, drug-eluting stents are expected to play a larger role in shaping treatment patterns worldwide. At the same time, covered stents and smaller-profile devices are expanding the range of cases that can be treated with stent-based approaches.

Market Overview

The global peripheral vascular stent market includes implantable devices used to support vessel patency in peripheral arteries and veins. These stents are used in a wide range of clinical applications, including iliac disease, femoral-popliteal disease, below-the-knee intervention, venous obstruction and other peripheral vascular conditions where maintaining vessel openness is critical to long-term treatment success.

Peripheral vascular stents remain a core part of endovascular intervention because they provide durable scaffolding and can address recoil, dissection and vessel collapse after angioplasty. However, the market today is more nuanced than it was in earlier years. Physicians are no longer using stents as a default option in every lesion type. Instead, stent choice is increasingly shaped by lesion complexity, anatomical location, expected long-term outcomes and whether future retreatment options need to be preserved.

Another defining feature of the peripheral vascular stent market is the balance between maturity and innovation. Some major stent indications, especially femoral-popliteal and iliac applications, are already well established and have reached a more mature growth stage. At the same time, product development continues to improve performance, particularly through covered designs, lower-profile delivery systems and ongoing research into drug-eluting technologies. This creates a market where growth is still present, but where new value often comes from product mix and technology upgrades rather than dramatic increases in procedure volume alone.

Market Drivers

Increased Penetration of Covered Stents

One of the most important drivers in the global peripheral vascular stent market is the increasing penetration of covered stents. As more covered stents gain approval for use in iliac, renal, superficial femoral artery and AV access procedures, physicians have greater flexibility in how they treat complex disease. Covered stents have become more popular because they can reduce rates of in-stent restenosis and make restenosis easier to manage when it does occur. In many arterial placements, stenosis is often limited to the proximal end, which can simplify retreatment.

Drug-Eluting Stents

Drug-eluting stents are also a major growth driver, even though this segment has faced past disruption. The market experienced a negative shock in 2019, but drug-eluting stents are still expected to be the fastest-growing segment within the broader peripheral vascular stent market over time. Clinical need remains strong, particularly in lesions where reducing restenosis is critical and where long-term patency can justify the higher device cost.

As more clinical studies are released and manufacturers continue to direct innovation toward this category, drug-eluting stents are expected to remain an important area of development. The relatively high price point of each device also means that adoption can have an outsized effect on market value. In addition, the expanding treatment of below-the-knee lesions supports a growing role for higher-performance stent technologies in more difficult anatomies.

Smaller-Diameter and Lower-Profile Stents

Lower-profile stents are helping open the market to procedures that were not previously possible or practical with larger devices. Smaller-diameter systems can be delivered into narrower and harder-to-access vessels, giving physicians more flexibility in treating distal disease and more complex anatomy. This is especially relevant in lower-extremity disease, where access, lesion length and vessel size can make treatment more challenging.

As stent profiles continue to decrease, more patients with critical limb ischemia and other advanced peripheral disease states can be treated with stent-based interventions. This expands the total treatable population and improves the utility of stents across more indications. These design improvements are also part of a wider trend toward more precise and less traumatic intervention.

Market Limiters

Trend Away from Paclitaxel Devices

A key limiter in the peripheral vascular stent market has been the shift away from paclitaxel-based devices following the FDA investigation into paclitaxel use in the periphery. Physician concern after 2019 created a strong negative effect on this segment, especially for drug-eluting technologies tied to paclitaxel. While the market is expected to recover over time, the pace of that recovery depends on renewed physician confidence, continued clinical research and sustained innovation.

Over the longer term, it is expected that the drug platforms used within peripheral drug-eluting stents may evolve. That transition will require more research, clinical study and investment. Until new approaches are fully validated and gain broad physician acceptance, this uncertainty will continue to limit the pace of DES growth compared with earlier expectations.

Market Maturity

Another major limiter is market maturity, especially in femoral-popliteal and iliac stenting. These are two of the largest segments within peripheral arterial stenting, but they are no longer early-growth markets. In many countries, these indications are already well established and procedure growth is now expected to track more closely with the aging population rather than expand at a rapid pace.

This maturity limits upside for the overall category because even when new products enter the market, they often replace or upgrade existing technologies rather than create entirely new volumes. As a result, growth tends to come from product mix improvement, pricing differences and incremental procedural expansion rather than major step changes in demand.

Complications After Stenting

Complications following stent placement also affect market growth. In-stent stenosis remains a common issue after many types of stenting and often requires ongoing management, including thrombectomy procedures and routine diagnostic follow-up to confirm vessel patency and device position. Because a permanently implanted device can complicate future treatment options, many physicians are increasingly selective about when to place a stent.

This has contributed to a broader trend away from permanent implants in some cases. Drug-eluting balloons and combination procedures can offer treatment pathways that preserve more future options and avoid leaving a permanent scaffold behind. As these alternative approaches gain traction, they can reduce the number of cases in which stenting is the preferred first-line solution.

Market Coverage and Data Scope

Quantitative Coverage

Market size, market shares, market forecasts, market growth rates, units sold and average selling prices.

Qualitative Coverage

Market drivers and limiters, growth trends, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios and leading competitors.

Time Frame

Base year 2025, historical data to 2022 and forecasts through 2032.

Regional Coverage

North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia-Pacific and Africa.

Data Types Included

Unit sales, average selling prices, procedure numbers, market size and growth trends.

This report is designed to give both strategic and operational visibility into the global peripheral vascular stent market, with enough detail to support forecasting, competitive benchmarking and commercial planning.

Markets Covered and Segmentation

  • The report covers the Global Peripheral Vascular Stent Market and further segments it into:

Arterial Stent Market

This segment includes peripheral vascular stents used in arterial indications such as iliac, femoral-popliteal, below-the-knee and other peripheral arterial treatments.

Venous Stent Market

This segment includes stents used to treat venous obstruction and related venous disease applications, an area of growing interest as venous intervention becomes more specialized.

Each segment is analyzed using market value, unit sales, procedure data and average selling prices, with historical trends and forecasts through 2032.

Competitive Analysis

W.L. Gore is one of the leading competitors in the global peripheral vascular stent market, with particular strength in covered stents. Its position has been supported by the successful development and commercialization of the VIABAHN covered stent platform. Incremental improvements, including heparin coating and lower-profile designs, have helped strengthen its performance in this category. The company also benefited from FDA approval of the GORE TIGRIS self-expanding vascular stent for use in the superficial femoral artery and proximal popliteal artery, reinforcing its relevance in peripheral arterial treatment.

Boston Scientific holds a strong position across several important peripheral stent segments. The company has a notable presence in the iliac and renal stent markets through the Express LD iliac stent and Express SD stents. In venous stenting, Boston Scientific is a leading competitor and built on its historical market share with Wallstent to support the launch of the VICI stent. With VICI gaining U.S. approval in 2019, the company remains well positioned to maintain strong market share in both domestic and global markets.

Abbott held the third-leading position in 2025. The company's Xience Prime BTK stent received CE mark approval in 2011 and secured meaningful share in the below-the-knee segment. Abbott Vascular also offers a broad range of balloon-expandable and self-expanding stents used across multiple peripheral indications. This broad product coverage helps the company stay active in both established and more specialized parts of the market.

Overall, competition in the global peripheral vascular stent market is shaped by product breadth, performance in specific lesion categories and the ability to support physicians with differentiated technology in a mature but still important market.

Technology and Practice Trends

One of the most important technology trends in the peripheral vascular stent market is the growing adoption of drug-eluting stents for treating peripheral arterial disease. These devices are designed to release medication directly at the site of implantation, which can reduce restenosis and improve long-term outcomes compared with traditional bare-metal stents in selected cases.

Covered stents are also gaining share as more physicians use them in iliac, renal, SFA and AV access procedures. Their ability to improve outcomes in certain complex lesions continues to support adoption.

Lower-profile stents represent another major trend. Smaller devices allow treatment in narrower and harder-to-reach vessels, expanding the range of peripheral lesions that can be approached with stent-based therapy.

At the same time, physician practice is becoming more selective. Rather than using stents in every lesion type, clinicians are increasingly balancing stenting against balloon-based and combination approaches. This means that future success in the market will depend not just on having a stent portfolio, but on having the right stent technologies for the right clinical scenarios.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

174 pages of detailed market analysis, data tables and forecasts.

Methodology Appendix and Acronym Glossary.

Why This Report

Where are the largest and most stable opportunities in the global peripheral vascular stent market?

How quickly are covered stents and drug-eluting stents changing product mix across arterial and venous applications?

What effect are physician concerns around paclitaxel and post-stenting complications having on future device demand?

How mature are the major stent indications, and where is meaningful growth still expected through 2032?

Which competitors hold the strongest positions in covered stents, venous stents and other high-value categories?

How are average selling prices, unit volumes and treatment trends shaping market value over time?

The Global Peripheral Vascular Stent Market Report from iData Research answers these questions with detailed market sizing, segmentation, competitive analysis and forecast modeling. Use it to benchmark competitors, evaluate regional opportunities and plan for growth in a mature but clinically important vascular device market.

TABLE OF CONTENT

List Of Figures

List Of Charts

Research Methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems And Perform Secondary Research
  • Step 3: Preparation For Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast And Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review And Market Release
  • Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

Peripheral Vascular Stent Market

  • 4.1 Executive Summary
    • 4.1.1 Global Peripheral Vascular Stent Market Overview
    • 4.1.2 Competitive Analysis
    • 4.1.3 Procedures Included
    • 4.1.4 Markets Included
    • 4.1.5 Regions Included
  • 4.2 Introduction
    • 4.2.1 Peripheral Arterial Stents
      • 4.2.1.1 Off-Label Use
      • 4.2.1.2 Covered Stents
      • 4.2.1.3 Drug-Eluting Stents
      • 4.2.1.4 Stent Length
    • 4.2.2 Venous Stents
  • 4.3 Procedure Numbers
    • 4.3.1 Total Peripheral Vascular Stenting Procedures
    • 4.3.2 Arterial Stent Procedures
    • 4.3.3 Venous Stent Procedures
  • 4.4 Market Overview
    • 4.4.1 By Segment
    • 4.4.2 By Region
  • 4.5 Market Analysis And Forecast
    • 4.5.1 Arterial Stent Market
      • 4.5.1.1 Bare-Metal Stent Market
      • 4.5.1.2 Bare-Metal Stent Unit Analysis By Delivery Platform
      • 4.5.1.3 Covered Stent Market
      • 4.5.1.4 Covered Stent Unit Analysis By Indication
      • 4.5.1.5 Drug-Eluting Stent Market
      • 4.5.1.6 Drug-Eluting Stent Unit Analysis By Indication
    • 4.5.2 Venous Stent Market
  • 4.6 Drivers And Limiters
    • 4.6.1 Market Drivers
    • 4.6.2 Market Limiters
  • 4.7 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

  • Chart 4-1: Peripheral Vascular Stent Market, Global, 2025 & 2032
  • Chart 4-2: Peripheral Vascular Stent Procedures, Global, 2025
  • Chart 4-3: Peripheral Vascular Stenting Procedures by Region, Global, 2022 - 2032
  • Chart 4-4: Peripheral Vascular Stent Market by Segment, Global, 2022 - 2032
  • Chart 4-5: Peripheral Vascular Stent Market by Region, Global, 2022 - 2032
  • Chart 4-6: Leading Competitors, Peripheral Vascular Stent Market, Global, 2025

LIST OF FIGURES

  • Figure 4-1: Peripheral Vascular Stent Procedures Covered
  • Figure 4-2: Peripheral Vascular Stent Markets Covered
  • Figure 4-3: Peripheral Vascular Stent Regions Covered, Global (1 of 2)
  • Figure 4-4: Peripheral Vascular Stent Regions Covered, Global (2 of 2)
  • Figure 4-5: Peripheral Vascular Stenting Procedures by Segment, Global, 2022 - 2032
  • Figure 4-6: Peripheral Vascular Stenting Procedures by Region, Global, 2022 - 2032
  • Figure 4-7: Peripheral Vascular Stenting Procedures by Country, North America, 2022 - 2032
  • Figure 4-8: Peripheral Vascular Stenting Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 4-9: Peripheral Vascular Stenting Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 4-10: Peripheral Vascular Stenting Procedures by Country, Western Europe, 2022 - 2032
  • Figure 4-11: Peripheral Vascular Stenting Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 4-12: Peripheral Vascular Stenting Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 4-13: Peripheral Vascular Stenting Procedures by Country, Middle East, 2022 - 2032
  • Figure 4-14: Peripheral Vascular Stenting Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 4-15: Peripheral Vascular Stenting Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 4-16: Peripheral Vascular Stenting Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 4-17: Peripheral Vascular Stenting Procedures by Country, Africa, 2022 - 2032
  • Figure 4-18: Arterial Stent Procedures by Segment, Global, 2022 - 2032
  • Figure 4-19: Arterial Stent Procedures by Region, Global, 2022 - 2032
  • Figure 4-20: Arterial Stent Procedures by Country, North America, 2022 - 2032
  • Figure 4-21: Arterial Stent Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 4-22: Arterial Stent Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 4-23: Arterial Stent Procedures by Country, Western Europe, 2022 - 2032
  • Figure 4-24: Arterial Stent Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 4-25: Arterial Stent Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 4-26: Arterial Stent Procedures by Country, Middle East, 2022 - 2032
  • Figure 4-27: Arterial Stent Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 4-28: Arterial Stent Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 4-29: Arterial Stent Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 4-30: Arterial Stent Procedures by Country, Africa, 2022 - 2032
  • Figure 4-31: Bare-Metal Stent Procedures by Region, Global, 2022 - 2032
  • Figure 4-32: Bare-Metal Stent Procedures by Country, North America, 2022 - 2032
  • Figure 4-33: Bare-Metal Stent Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 4-34: Bare-Metal Stent Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 4-35: Bare-Metal Stent Procedures by Country, Western Europe, 2022 - 2032
  • Figure 4-36: Bare-Metal Stent Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 4-37: Bare-Metal Stent Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 4-38: Bare-Metal Stent Procedures by Country, Middle East, 2022 - 2032
  • Figure 4-39: Bare-Metal Stent Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 4-40: Bare-Metal Stent Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 4-41: Bare-Metal Stent Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 4-42: Bare-Metal Stent Procedures by Country, Africa, 2022 - 2032
  • Figure 4-43: Covered Stent Procedures by Region, Global, 2022 - 2032
  • Figure 4-44: Covered Stent Procedures by Country, North America, 2022 - 2032
  • Figure 4-45: Covered Stent Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 4-46: Covered Stent Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 4-47: Covered Stent Procedures by Country, Western Europe, 2022 - 2032
  • Figure 4-48: Covered Stent Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 4-49: Covered Stent Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 4-50: Covered Stent Procedures by Country, Middle East, 2022 - 2032
  • Figure 4-51: Covered Stent Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 4-52: Covered Stent Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 4-53: Covered Stent Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 4-54: Covered Stent Procedures by Country, Africa, 2022 - 2032
  • Figure 4-55: Drug-Eluting Stent Procedures by Region, Global, 2022 - 2032
  • Figure 4-56: Drug-Eluting Stent Procedures by Country, North America, 2022 - 2032
  • Figure 4-57: Drug-Eluting Stent Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 4-58: Drug-Eluting Stent Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 4-59: Drug-Eluting Stent Procedures by Country, Western Europe, 2022 - 2032
  • Figure 4-60: Drug-Eluting Stent Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 4-61: Drug-Eluting Stent Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 4-62: Drug-Eluting Stent Procedures by Country, Middle East, 2022 - 2032
  • Figure 4-63: Drug-Eluting Stent Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 4-64: Drug-Eluting Stent Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 4-65: Drug-Eluting Stent Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 4-66: Drug-Eluting Stent Procedures by Country, Africa, 2022 - 2032
  • Figure 4-67: Venous Stent Procedures by Region, Global, 2022 - 2032
  • Figure 4-68: Venous Stent Procedures by Country, North America, 2022 - 2032
  • Figure 4-69: Venous Stent Procedures by Country, Latin America, 2022 - 2032 (1 of 2)
  • Figure 4-70: Venous Stent Procedures by Country, Latin America, 2022 - 2032 (2 of 2)
  • Figure 4-71: Venous Stent Procedures by Country, Western Europe, 2022 - 2032
  • Figure 4-72: Venous Stent Procedures by Country, Central & Eastern Europe, 2022 - 2032 (1 of 2)
  • Figure 4-73: Venous Stent Procedures by Country, Central & Eastern Europe, 2022 - 2032 (2 of 2)
  • Figure 4-74: Venous Stent Procedures by Country, Middle East, 2022 - 2032
  • Figure 4-75: Venous Stent Procedures by Country, Asia-Pacific, 2022 - 2032 (1 of 3)
  • Figure 4-76: Venous Stent Procedures by Country, Asia-Pacific, 2022 - 2032 (2 of 3)
  • Figure 4-77: Venous Stent Procedures by Country, Asia-Pacific, 2022 - 2032 (3 of 3)
  • Figure 4-78: Venous Stent Procedures by Country, Africa, 2022 - 2032
  • Figure 4-79: Peripheral Vascular Stent Market by Segment, Global, 2022 - 2032 (US$M)
  • Figure 4-80: Peripheral Vascular Stent Market by Region, Global, 2022 - 2032 (US$M)
  • Figure 4-81: Arterial Stent Market by Segment, Global, 2022 - 2032 (US$M)
  • Figure 4-82: Total Arterial Stent Market, Global, 2022 - 2032
  • Figure 4-83: Units Sold by Region, Arterial Stent Market, Global, 2022 - 2032
  • Figure 4-84: Average Selling Price by Region, Arterial Stent Market, Global, 2022 - 2032 (US$)
  • Figure 4-85: Market Value by Region, Arterial Stent Market, Global, 2022 - 2032 (US$M)
  • Figure 4-86: Bare-Metal Stent Market by Segment, Global, 2022 - 2032 (US$M)
  • Figure 4-87: Total Bare-Metal Stent Market, Global, 2022 - 2032
  • Figure 4-88: Units Sold by Region, Bare-Metal Stent Market, Global, 2022 - 2032
  • Figure 4-89: Average Selling Price by Region, Bare-Metal Stent Market, Global, 2022 - 2032 (US$)
  • Figure 4-90: Market Value by Region, Bare-Metal Stent Market, Global, 2022 - 2032 (US$M)
  • Figure 4-91: Bare-Metal Carotid Stent Market, Global, 2022 - 2032
  • Figure 4-92: Units Sold by Region, Bare-Metal Carotid Stent Market, Global, 2022 - 2032
  • Figure 4-93: Average Selling Price by Region, Bare-Metal Carotid Stent Market, Global, 2022 - 2032 (US$)
  • Figure 4-94: Market Value by Region, Bare-Metal Carotid Stent Market, Global, 2022 - 2032 (US$M)
  • Figure 4-95: Bare-Metal Iliac Stent Market, Global, 2022 - 2032
  • Figure 4-96: Units Sold by Region, Bare-Metal Iliac Stent Market, Global, 2022 - 2032
  • Figure 4-97: Average Selling Price by Region, Bare-Metal Iliac Stent Market, Global, 2022 - 2032 (US$)
  • Figure 4-98: Market Value by Region, Bare-Metal Iliac Stent Market, Global, 2022 - 2032 (US$M)
  • Figure 4-99: Bare-Metal Renal Stent Market, Global, 2022 - 2032
  • Figure 4-100: Units Sold by Region, Bare-Metal Renal Stent Market, Global, 2022 - 2032
  • Figure 4-101: Average Selling Price by Region, Bare-Metal Renal Stent Market, Global, 2022 - 2032 (US$)
  • Figure 4-102: Market Value by Region, Bare-Metal Renal Stent Market, Global, 2022 - 2032 (US$M)
  • Figure 4-103: Bare-Metal Fem-Pop Stent Market, Global, 2022 - 2032
  • Figure 4-104: Units Sold by Region, Bare-Metal Fem-Pop Stent Market, Global, 2022 - 2032
  • Figure 4-105: Average Selling Price by Region, Bare-Metal Fem-Pop Stent Market, Global, 2022 - 2032 (US$)
  • Figure 4-106: Market Value by Region, Bare-Metal Fem-Pop Stent Market, Global, 2022 - 2032 (US$M)
  • Figure 4-107: Bare-Metal Infra-Pop Stent Market, Global, 2022 - 2032
  • Figure 4-108: Units Sold by Region, Bare-Metal Infra-Pop Stent Market, Global, 2022 - 2032
  • Figure 4-109: Average Selling Price by Region, Bare-Metal Infra-Pop Stent Market, Global, 2022 - 2032 (US$)
  • Figure 4-110: Market Value by Region, Bare-Metal Infra-Pop Stent Market, Global, 2022 - 2032 (US$M)
  • Figure 4-111: Bare-Metal Sten Unit Analysis by Delivery Platform, Global, 2022 - 2032
  • Figure 4-112: Units Sold by Region, Self-Expanding Bare-Metal Stent Units, Global, 2022 - 2032
  • Figure 4-113: Units Sold by Region, Balloon-Expanding Bare-Metal Stent Market, Global, 2022 - 2032
  • Figure 4-114: Covered Stent Market, Global, 2022 - 2032
  • Figure 4-115: Units Sold by Region, Covered Stent Market, Global, 2022 - 2032
  • Figure 4-116: Average Selling Price by Region, Covered Stent Market, Global, 2022 - 2032 (US$)
  • Figure 4-117: Market Value by Region, Covered Stent Market, Global, 2022 - 2032 (US$M)
  • Figure 4-118: Covered Stent Unis Analysis by Indication, Global, 2022 - 2032
  • Figure 4-119: Units Sold by Region, Iliac Covered Stent Market, Global, 2022 - 2032
  • Figure 4-120: Units Sold by Region, Fem-Popliteal Covered Stent Market, Global, 2022 - 2032
  • Figure 4-121: Units Sold by Region, AV-Access Covered Stent Market, Global, 2022 - 2032
  • Figure 4-122: Drug-Eluting Stent Market, Global, 2022 - 2032
  • Figure 4-123: Units Sold by Region, Drug-Eluting Stent Market, Global, 2022 - 2032
  • Figure 4-124: Average Selling Price by Region, Drug-Eluting Stent Market, Global, 2022 - 2032 (US$)
  • Figure 4-125: Market Value by Region, Drug-Eluting Stent Market, Global, 2022 - 2032 (US$M)
  • Figure 4-126: Drug-Eluting Stent Unit analysis by Indication, U.S., 2022 - 2032
  • Figure 4-127: Units Sold by Region, SFA Drug-Eluting Stent Market, Global, 2022 - 2032
  • Figure 4-128: Units Sold by Region, Infra-Popliteal Drug-Eluting Stent Market, Global, 2022 - 2032
  • Figure 4-129: Venous Stent Market, Global, 2022 - 2032
  • Figure 4-130: Units Sold by Region, Venous Stent Market, Global, 2022 - 2032
  • Figure 4-131: Average Selling Price by Region, Venous Stent Market, Global, 2022 - 2032 (US$)
  • Figure 4-132: Market Value by Region, Venous Stent Market, Global, 2022 - 2032 (US$M)
  • Figure 4-133: Leading Competitors, Peripheral Vascular Stent Market, Global, 2025